A
Allarity Therapeutics, Inc. (ALLR)
NCM – Real Time Price. Currency in USD
1.52
-0.16 (-9.52%)
At close: May 12, 2026, 4:00 PM EDT
1.51
-0.01 (-0.65%)
After-hours: May 12, 2026, 7:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.52
-0.16 (-9.52%)
At close: May 12, 2026, 4:00 PM EDT
1.51
-0.01 (-0.65%)
After-hours: May 12, 2026, 7:31 PM EDT
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
| Name | Position |
|---|---|
| Dr. Jeremy R. Graff Ph.D. | President & Chief Development Officer |
| Dr. Jose L. Iglesias M.D. | Consultant Chief Medical Officer |
| Dr. Steen Meier Knudsen Ph.D. | Founder & Chief Scientific Officer |
| Mr. Jeffrey S. Ervin M.B.A. | Chief Financial Officer |
| Mr. Thomas H. Jensen | Founder, CEO & Director |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 8-K | ea0289893-8k_allarity.htm |
| 2026-05-06 | 8-K | ea0289243-8k_allarity.htm |
| 2026-04-30 | DEF 14A | ea0287703-01.htm |
| 2026-04-28 | 8-K | ea0287908-8k_allarity.htm |
| 2026-04-24 | S-3/A | ea0287396-s3a1_allarity.htm |
| 2026-04-22 | 8-K | ea0287156-8k_allarity.htm |
| 2026-04-10 | PRE 14A | ea0285611-pre14a_allarity.htm |
| 2026-04-01 | 8-K | ea0279571-8k_allarity.htm |
| 2026-03-30 | 10-K | allr20251231_10k.htm |
| 2026-03-09 | 8-K | ea0280539-8k_allarity.htm |